B Csernus
Overview
Explore the profile of B Csernus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bognar A, Csernus B, Bodor C, Reiniger L, Szepesi A, Toth E, et al.
Leukemia
. 2005 Jun;
19(9):1656-62.
PMID: 15973453
To characterize the pathways of bone marrow (BM) involvement of follicular lymphoma (FL), we performed morphological and immunophenotypical analysis of tumor cells from lymph nodes (LNs) and corresponding BMs in...
2.
Timar B, Fulop Z, Csernus B, Angster C, Bognar A, Szepesi A, et al.
Leukemia
. 2003 Dec;
18(2):326-30.
PMID: 14671632
Patients with chronic lymphocytic leukemia (CLL) may develop diffuse large B-cell lymphoma (DLBL), also known as Richter's syndrome. Mutational status of immunoglobulin (Ig) heavy-chain variable region (VH) genes have prognostic...
3.
Fulop Z, Csernus B, Timar B, Szepesi A, Matolcsy A
Leukemia
. 2003 Feb;
17(2):411-5.
PMID: 12592341
Chronic lymphocytic leukemia (CLL) is an indolent B cell non-Hodgkin lymphoma (NHL) that may transform into diffuse large B cell lymphoma (DLBL). This transformation is referred to as Richter's syndrome...
4.
Kovacs M, Schally A, Csernus B, Busto R, Rekasi Z, Nagy A
J Neuroendocrinol
. 2002 Mar;
14(1):5-13.
PMID: 11903807
A cytotoxic analogue of LH-RH, AN-207, consisting of 2-pyrrolinodoxorubicin (AN-201) linked to carrier [D-Lys6]LH-RH, was developed for targeted therapy of cancers expressing LH-RH-receptors. To determine its possible side-effects on the...
5.
Plonowski A, Schally A, Koppan M, Nagy A, Arencibia J, Csernus B, et al.
Cancer
. 2001 Sep;
92(5):1168-76.
PMID: 11571730
Background: Cytotoxic analogs of somatostatin (SST), such as AN-238, which consists of 2-pyrrolinodoxorubicin (AN-201) linked to the SST carrier RC-121, can be targeted to tumors that express SST receptors. Because...
6.
Szepeshazi K, Schally A, Halmos G, Sun B, Hebert F, Csernus B, et al.
Clin Cancer Res
. 2001 Sep;
7(9):2854-61.
PMID: 11555603
Purpose: The expression of somatostatin receptors (SSTRs) allows the localization and treatment of some tumors with radiolabeled SST analogues. We investigated whether SSTRs on human pancreatic cancer lines xenografted into...
7.
Rekasi Z, Schally A, Plonowski A, Czompoly T, Csernus B, Varga J
Prostate
. 2001 Aug;
48(3):188-99.
PMID: 11494334
Background: Prostate-specific antigen (PSA) is the best tumor marker for diagnosis and prognosis of prostatic carcinoma. The secretion of PSA from LNCaP human prostate cancer cells is influenced by acute...
8.
Rekasi Z, Varga J, Schally A, Plonowski A, Halmos G, Csernus B, et al.
Peptides
. 2001 Jun;
22(6):879-86.
PMID: 11390017
We evaluated the effects of GHRH antagonists on the proliferation of MiaPaCa-2 human pancreatic cancer cells and cAMP signaling in vitro. GHRH antagonists inhibited the proliferation of MiaPaCa-2 cells in...
9.
Kovacs M, Schally A, Csernus B, Rekasi Z
Proc Natl Acad Sci U S A
. 2001 Feb;
98(4):1829-34.
PMID: 11172036
The mechanisms through which LH-RH antagonists suppress gonadotroph functions and LH-RH receptor (LH-RH-R) production are incompletely understood. To elucidate these mechanisms, we investigated the effects of Cetrorelix on the mRNA...
10.
SZEREDAY Z, Csernus B, Nagy M, Laszlo T, Warnke R, Matolcsy A
Am J Pathol
. 2000 Mar;
156(3):1017-24.
PMID: 10702417
Follicular lymphoma (FL) is a B cell non-Hodgkin's lymphoma (NHL) that frequently displays a t(14;18) translocation. Clonal evolution and histological transformation of FL is frequently associated with the accumulation of...